LNWTC
BSX icon

Laird Norton Wetherby Trust Company’s Boston Scientific BSX Stock Holding History

Laird Norton Wetherby Trust Company’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.05M Sell
47,988
-2,512
-5% -$136K 0.04% 333
2026
Q1 		$3.17M Sell
50,500
-4,592
-8% -$367K 0.07% 227
2025
Q4 		$5.25M Buy
+55,092
New +$5.4M 0.11% 150

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Laird Norton Wetherby Trust Company's BSX Position: Q2 2026 in Review

Laird Norton Wetherby Trust Company reduced its Boston Scientific (BSX) stake by 5% in Q2 2026, selling an estimated $136K and leaving 47,988 shares worth $2.05M. The position accounts for 0.04% of the portfolio, ranked #333.

Laird Norton Wetherby Trust Company first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. The position peaked at $5.25M in Q4 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Laird Norton Wetherby Trust Company held 47,988 shares of Boston Scientific worth $2.05M as of Q2 2026.
  • Laird Norton Wetherby Trust Company sold 2,512 Boston Scientific shares in Q2 2026, an estimated $136K.
  • Boston Scientific made up 0.04% of Laird Norton Wetherby Trust Company's portfolio in Q2 2026, its #333 holding.
  • Laird Norton Wetherby Trust Company first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • Laird Norton Wetherby Trust Company's Boston Scientific position peaked at $5.25M in Q4 2025.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Laird Norton Wetherby Trust Company's 13F filing for Q2 2026, filed 14 Aug 2026.